Among the nine recurrently hypo-methylated and over-expressed genes was the gene “preferentially expressed antigen in melanoma” (PRAME, 11/19 cell lines), which is over-expressed and a prognostic marker for clinical outcome in various types of cancers [39]. The gene discussed is PRAME; the disease is melanoma.